|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 03, 2018 11:21PM
|
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 04, 2018 07:57AM
|
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 04, 2018 10:22AM
|
|
Re: Mace
|
3
|
Resverlogix Corp.
|
May 07, 2016 08:57PM
|
|
Re: Lowest volume in a long time?
|
2
|
Resverlogix Corp.
|
Dec 18, 2018 10:16AM
|
|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk - Bear
|
3
|
Resverlogix Corp.
|
Jun 06, 2020 01:38PM
|
|
Re: Low Impact Journals
|
4
|
Resverlogix Corp.
|
Apr 15, 2019 04:34PM
|
|
Re: Losing exclusivity on Aberatirone may not be all that bad for JNJ or ZEL
|
4
|
Zenith Epigenetics
|
Nov 22, 2018 05:53PM
|
|
Re: Looks like Top SoC for Diabetes is evolving yet again:
|
2
|
Resverlogix Corp.
|
Jan 17, 2020 09:14PM
|
|
Re: Looks like Top SoC for Diabetes is evolving yet again:
|
5
|
Resverlogix Corp.
|
Jan 17, 2020 04:14PM
|
|
Re: Looking over Amarin does lead to one obvious conclusion...
|
1
|
Resverlogix Corp.
|
Feb 13, 2019 01:52PM
|
|
Re: Looking over Amarin does lead to one obvious conclusion...
|
4
|
Resverlogix Corp.
|
Feb 14, 2019 10:54AM
|
|
Re: Looking over Amarin does lead to one obvious conclusion...
|
2
|
Resverlogix Corp.
|
Feb 14, 2019 12:09PM
|
|
Re: Looking for clues:
|
3
|
Resverlogix Corp.
|
Nov 30, 2019 10:59AM
|
|
Re: Looking for clues:
|
4
|
Resverlogix Corp.
|
Nov 30, 2019 02:33PM
|
|
Re: Looking for clues:
|
2
|
Resverlogix Corp.
|
Nov 30, 2019 03:09PM
|
|
Re: Looking for clues:
|
1
|
Resverlogix Corp.
|
Nov 30, 2019 03:26PM
|
|
Re: Looking for clues:
|
2
|
Resverlogix Corp.
|
Nov 30, 2019 04:42PM
|
|
Re: Looking at the language from the press release
|
7
|
Resverlogix Corp.
|
Oct 05, 2019 01:40PM
|
|
Re: Looking at the language from the press release
|
6
|
Resverlogix Corp.
|
Oct 05, 2019 02:43PM
|
